IPO - PURPLE BIOTECH LTD.

Form Type: 424B5

Filing Date: 2025-01-06

Corporate Action: Ipo

Type: New

Accession Number: 000121390025001183

Filing Summary: Purple Biotech Ltd. filed a prospectus supplement on January 6, 2025, pursuant to Rule 424(b)(5) to amend previous prospectuses related to the offer and sale of American Depositary Shares (ADSs) with an aggregate offering price of up to $1,330,000. This update was necessary following the sale of approximately $6.6 million worth of ADSs to date. The company has a public float valued at $21,423,330, based on the last reported prices of their ADSs and ordinary shares. They have also outlined potential risks for investors and the implications of potentially being classified as a Passive Foreign Investment Company (PFIC). Jefferies LLC is managing the sale under the Open Market Sale Agreement. The filing emphasizes that investment in these securities carries risks and further details are available in the prior prospectuses and the Sales Agreement.

Document Link: View Document